Revenio 

$28.35
14
+$0+0% Tuesday 20:00

統計

當日最高
28.35
當日最低
28.35
52週最高
44
52週最低
28.35
成交量
835
平均成交量
0
市值
840.5M
市盈率
37.3
股息收益率
1.45%
股息
0.41

即將到來

股息

1.45%股息收益率
10年增長
7.14%
5年增長率
20.95%
3年增長率
2.63%
1年增長率
6.22%

收益

31Oct預期
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q1 2024
Q2 2024
下一個
0.13
0.16
0.19
0.22
預期每股收益
0.21919392
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 REVXF 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Medical Specialties
Health Technology
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, rest of Europe, North America, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; and iCare TONOVET an IOP measuring on animal patients by general veterinary practitioners, veterinary ophthalmologists, and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON AF, a device with confocal retinal imaging; and DRSplus, a device for pupil imaging; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. In addition, the company offers Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.
Show more...
首席執行官
Mr. Jouni Toijala B.Sc., M.B.A.
員工
229
國家
FI
ISIN
FI0009010912

上市公司